Advanced Enzyme Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2026 ,inter alia, to consider and approve Un-audited Financial ....
ADVENZYMES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Advanced Enzyme Technologies has informed the stock exchanges that its Board of Directors will meet on January 31, 2026 to consider and approve the un-audited financial results (both standalone and consolidated) for the quarter and nine months ended December 31, 2025. The trading window for dealing in the company's securities will remain closed until February 2, 2026. No financial figures or operational details have been disclosed in this intimation. The results are expected to be announced shortly after the board meeting.
This is a routine procedural filing ahead of the Q3FY26 earnings announcement. Shareholders should watch for the actual results on or after January 31, 2026; the trading window closure means insiders cannot trade until February 2, 2026.